Mesoblast (ASX:MSB) receives ethics approval to treat Covid-19 patients
September 2nd, 2020 | 🕒
https://www.ispeech.org Mesoblast (ASX:MSB) today announced that it has received ethics approval to include Australian hospitals in the Phase 3 randomized
Gloss